Family Office Of America (FOFA) Change in Cash (2021 - 2026)
Family Office Of America (FOFA) reported Change in Cash of $187422.0 for Q1 2026, down 66.02% on a YoY basis from $551636.0 in Q1 2025, and up 127.9% sequentially from -$671800.0 in Q4 2025.
Family Office Of America (FOFA) Change in Cash (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Change in Cash data on file, last reported at $187422.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 66.02% year-over-year to $187422.0; the trailing twelve-month figure through Mar 2026 stood at -$222002.0 (down 146.77% YoY), and the FY2025 full-year result was $142212.0, up 1174.87% from the prior year.
- Change in Cash rose to $187422.0 in Q1 2026, from -$671800.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $551636.0 in Q1 2025 to a low of -$671800.0 in Q4 2025.
- A 5-year average of -$10886.1 and a median of -$23296.0 in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash tumbled 3110.73% in 2024 and jumped 1591.05% in 2025, its largest moves.
- Tracing FOFA's Change in Cash over 5 years: stood at -$102094.0 in 2022, then surged by 101.08% to $1100.0 in 2023, then plunged by 3110.73% to -$33118.0 in 2024, then plunged by 1928.5% to -$671800.0 in 2025, then surged by 127.9% to $187422.0 in 2026.
- Business Quant data shows FOFA's Change in Cash at $187422.0 in Q1 2026, -$671800.0 in Q4 2025, and $242325.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 187,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,422.00 |
| Dec 31, 2025 | -671,800.00 |
| Sep 30, 2025 | 242,325.00 |
| Jun 30, 2025 | 20,051.00 |
| Mar 31, 2025 | 551,636.00 |
| Dec 31, 2024 | -33,118.00 |
| Sep 30, 2024 | -16,252.00 |
| Jun 30, 2024 | -27,615.00 |
| Mar 31, 2024 | 88,140.00 |
| Dec 31, 2023 | 1,100.00 |
| Sep 30, 2023 | -23,296.00 |
| Jun 30, 2023 | 8,522.00 |
| Mar 31, 2023 | -53,753.00 |
| Dec 31, 2022 | -102,094.00 |
| Sep 30, 2022 | -54,335.00 |
| Jun 30, 2022 | -172,198.00 |
| Mar 31, 2022 | -129,799.00 |
| Dec 31, 2021 | -175,637.00 |
| Sep 30, 2021 | -357,987.00 |